Literature DB >> 1524089

A unique circulating inhibitor with specificity for coagulation factor X.

M W Lankiewicz1, W R Bell.   

Abstract

An 84-year-old woman presented with extensive cutaneous and gastrointestinal bleeding. Initial laboratory studies revealed a prolonged prothrombin time and activated partial thromboplastin time. Further investigations revealed a circulating anticoagulant with specificity for factor X. The patient's hemorrhage resolved with supportive measures only. Approximately 11 months after presentation, the inhibitor disappeared.

Entities:  

Mesh:

Year:  1992        PMID: 1524089     DOI: 10.1016/0002-9343(92)90244-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  2 in total

1.  An acquired, calcium-dependent, factor X inhibitor.

Authors:  George J Broze
Journal:  Blood Cells Mol Dis       Date:  2013-09-26       Impact factor: 3.039

2.  Successful Treatment of Factor X Deficiency in a Patient with Lymphoplasmacytic Lymphoma with Bendamustine Plus Rituximab Regimen: A Case Report and Literature Review.

Authors:  Tarinee Rungjirajittranon; Yingyong Chinthammitr; Chattree Hantaweepant
Journal:  J Blood Med       Date:  2021-10-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.